Roche Pharma. File
| Photo Credit: Reuters
Roche Pharma on Saturday (September 13, 2025) said it has partnered with ten government hospitals to strengthen clinical trial capabilities in India.
Under the initiative, nearly 400 professionals have been trained, comprising investigators, ethics committee members and other resources as per global Good Clinical Practice (GCP) standards.
“By equipping leading government hospitals with global-standard clinical trial capabilities, we are helping to bring innovations faster to India. This is a crucial step toward building equitable healthcare and shaping treatments that are relevant for India,” said Sivabalan Sivanesan, Country Medical Director, Roche Pharma India.
The Advanced Inclusive Research (AIR) Site Alliance is Roche’s flagship global initiative designed to expand access to clinical trials for underrepresented populations.
Already implemented in the U.S., the U.K., Canada, and Africa, the AIR Site Alliance is now active in India.
India accounts for 17% of the world’s population and 20% of the global disease burden, yet fewer than 4% of global clinical trials are conducted in the country.
The Initiative aligns with CDSCO priorities to boost participation of government sites in Phase 3 and 4 trials.
Published – September 13, 2025 10:11 pm IST
Source: https://www.thehindu.com/business/roche-pharma-partners-with-10-govt-hospitals-to-bolster-clinical-trial-capabilities-in-india/article70046752.ece
